Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction - Wikidata - wikimedia - TriplyDB

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

http://www.wikidata.org/entity/Q36379436

about

Role of bile acids in carcinogenesis of pancreatic cancer: An old topic with new perspective.Fatty liver diseases, bile acids, and FXR Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism Gut-Brain Cross-Talk in Metabolic Control.Obesity: Current and potential pharmacotherapeutics and targets.β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue.An Intestinal Microbiota-Farnesoid X Receptor Axis Modulates Metabolic Disease.Bariatric surgery and type 2 diabetes: are there weight loss-independent therapeutic effects of upper gastrointestinal bypass?An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice.Non-alcoholic fatty liver and the gut microbiota.Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.The antiandrogen flutamide is a novel aryl hydrocarbon receptor ligand that disrupts bile acid homeostasis in mice through induction of Abcc4 Recent advances in understanding noroviruses.Conformational modulation of the farnesoid X receptor by prenylflavonoids: Insights from hydrogen deuterium exchange mass spectrometry (HDX-MS), fluorescence titration and molecular docking studies.Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.Clinical implications of understanding the association between oxidative stress and pediatric NAFLD.Intestinal bile acid receptors are key regulators of glucose homeostasis.Roles of Ileal ASBT and OSTα-OSTβ in Regulating Bile Acid Signaling.Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.Microbiota: a key orchestrator of cancer therapy.Bile acids and bariatric surgery.Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions.Effects of Consuming Xylitol on Gut Microbiota and Lipid Metabolism in Mice.Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.Host-Microbiota Mutualism in Metabolic Diseases.Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice.Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans.FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice.Recent advances in understanding bile acid homeostasis.Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone-Kidney-Gut Axis.Reciprocal interactions between bile acids and gut microbiota in human liver diseases.Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition.Bile acid metabolism in liver pathobiology.Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis.Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota.Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases.Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis.Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice.Bile acids in glucose metabolism in health and disease.

P2860

Q27693345-DF3871AB-6A63-47C9-88C0-0A472C674C73 Q28068199-5468C6E3-22E2-425D-9BA9-409D36AD1602 Q28821039-4B00F785-A898-433B-B57B-2FCD95139FFA Q30235568-6DF7C716-D2FB-4609-B3A2-BD9EFDB80777 Q30243992-C7FAEAF7-A936-4F11-AE6A-138BB5E31A42 Q33578966-266D4EEC-4A71-4505-9FFD-4E0AE3AC49EC Q36136449-5DB0607D-E65E-469E-B7A9-9F9E3CA177C9 Q36163431-5E00815A-7A28-4907-8FC3-939DDDF39084 Q36287039-BA7D5AF9-6109-46C8-94B7-644FE777DFF7 Q37215934-DE3E2078-3FA9-416C-B9AB-02E003829C36 Q37538343-CC0511EE-C184-4070-BEBB-4771A5C30E6E Q38749517-D3FB1490-AB8A-47B6-8209-6FFD68BB95EC Q38761262-19598E82-9B31-4998-A600-7155D0724E0A Q38809529-9CAC7E2C-1CEA-4939-96F6-C6CEB6585480 Q38976871-04943598-C026-44A5-BB21-9454EF84A23B Q38978486-3DEB19DF-AF4F-41DD-9646-F0F9F611C240 Q39009492-94A743A6-6131-4A41-BA4E-E19A3BE05F7B Q39156527-C107987E-5835-47CF-8B46-AD5E57047B93 Q39156532-28B00CA6-BBC1-4C27-A2BB-77CB9FAD6483 Q39183428-C7EE4B3D-6937-4A83-A6F0-849B1D2EB6FE Q39228891-5694AD2B-B879-417D-9286-03851A632889 Q40966013-E8BC2FC2-25DB-4277-B5BD-9E83A6996F7F Q41195441-C90D86B3-451E-4EA5-A26D-2998AA9FAD2A Q41382617-9BC98AD2-6522-4FC9-B71F-A036B394A5E1 Q43809679-8AE62F12-A858-4985-BE91-628438467EE2 Q45955303-ED81634D-5385-42F1-9858-68107E23EA06 Q46488398-2499AFEC-8EEF-42E0-BF0C-E58239CC1221 Q46980569-93763014-7558-4D11-AE77-7E10C30DB6A3 Q47130145-E439E07F-8D4D-4B85-A838-83C726AB6D29 Q47162245-CFA7FE8E-63E9-42DD-A61A-6A684DD2A413 Q47221759-3A0623F6-AECD-4766-BC54-380105F0C457 Q47389652-DF3CFDE8-F47C-442C-A2A4-0C3929B458D0 Q47608553-6C219EBB-902D-4A0F-8F10-D2B70B7592B6 Q47645986-AD40AA41-042F-49B8-AEEB-9BBCDF2090AB Q47648812-E5B04E87-EB03-4DEB-AE1E-7099B1261C9A Q47666074-923CCFAC-DB76-483A-AD87-BE4B5C497E9D Q47779219-C377529F-5B76-414F-9831-DD7F82264605 Q47877023-2976F599-7E34-4155-93BC-0607EB66D86C Q47958825-C2F4D4E5-A541-42A2-9D3A-D059E8DEA242 Q48042610-3214989D-8FB5-40A2-88E2-8A07AF1CCE69

P2860

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

http://www.wikidata.org/entity/Q36379436

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Intestine-selective farnesoid ...... -related metabolic dysfunction

@ast

Intestine-selective farnesoid ...... -related metabolic dysfunction

@en

type

label

Intestine-selective farnesoid ...... -related metabolic dysfunction

@ast

Intestine-selective farnesoid ...... -related metabolic dysfunction

@en

prefLabel

Intestine-selective farnesoid ...... -related metabolic dysfunction

@ast

Intestine-selective farnesoid ...... -related metabolic dysfunction

@en

P1433

Q36379436-AD5E1285-12F1-455A-B009-B9D84262CF79

P1476

Q36379436-F12E1E4C-72A4-438B-AAC8-1F3F5C3DBB31

P2093

Q36379436-0E8286F9-39E5-4417-B905-199141C5B9D4

Q36379436-257D1C4E-4FBA-410F-879E-2F3C60EBE66A

Q36379436-2C5C254B-BF17-424A-81D7-2DC26F5A888D

Q36379436-463A5DF2-68EB-41FE-ACA7-DD73C7F87F28

Q36379436-5A4FC11D-DA04-4810-B43A-75A714681599

Q36379436-932A4F33-5AF0-4D88-A495-6D0C58A869B3

Q36379436-AE0A6189-3A3C-46EC-9CB6-DE5756FBF91C

Q36379436-B1491D7D-6264-4A61-B67B-B3419D17469C

Q36379436-D4C27F2C-92E2-4C4F-B145-B8B76C924653

Q36379436-DC80A2AF-D198-4B59-A22F-E9174023467C

P2860

Q36379436-02C133C5-EA3B-4D0D-8236-F2FE2DC4DDDA

Q36379436-074E4CD0-9048-4945-9C0D-617ECE73672F

Q36379436-0D7AF832-FB17-4EC3-840C-5F2AA0D80CA0

Q36379436-10A43ED0-C549-407D-922C-630D16B3697E

Q36379436-14C16B6A-1EC8-46E9-8B11-5A0CE93F2744

Q36379436-1B1C2508-6C08-4C17-A5AA-EA07CE56A168

Q36379436-205BEF0B-4183-412D-BDDC-ED01D2D4CCDA

Q36379436-20FA7FD2-9B13-4346-87C4-7AC0261FDD0E

Q36379436-24601DDE-D769-4E72-A1EF-2349C5C15C9E

Q36379436-2B4146CA-B9DC-4105-9754-7DF9F17BCC6D

P2888

Q36379436-BFD764BA-8B67-4328-AC8E-BE1AEECD85CE

P304

Q36379436-414DE801-A99D-49CB-86E9-057CAFA42B3E

P31

Q36379436-E54486CB-220B-47EF-9AFF-50E011A984B5

P356

Q36379436-701203B4-7BF4-4277-9C0D-5D8919441641

P407

Q36379436-F66E1044-A21B-4117-8089-4CE63A1F01FB

P478

Q36379436-4DC362B3-4316-4C7A-8463-0BD62666719B

P50

Q36379436-2E03C051-EA10-46CF-83B6-0F4F8517C307

Q36379436-956AB177-16F3-4722-956F-12E2EFAD995C

Q36379436-CFF4776D-A2A2-49C0-939B-02C70AA6F089

P577

Q36379436-C1C38805-D87C-4A73-9EE9-BC105C6BD2AA

P5875

Q36379436-50B1FEF7-27BA-463F-9BBA-BFD9A8C87908

P698

Q36379436-21057538-1805-49CE-8F78-1A6BBAC3E5B2

P921

Q36379436-10E6CED2-EEA4-4704-92B2-8C0D484DFC94

P932

Q36379436-B529651D-3871-4EA5-AE87-33A2F7085045

P356

P1433

Nature Communications

P1476

Intestine-selective farnesoid ...... -related metabolic dysfunction

@en

P2093

Cen Xie

http://www.w3.org/2001/XMLSchema#string

Chad N Brocker

http://www.w3.org/2001/XMLSchema#string

Dhimant Desai

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Jingmin Shi

http://www.w3.org/2001/XMLSchema#string

Kristopher W Krausz

http://www.w3.org/2001/XMLSchema#string

Oksana Gavrilova

http://www.w3.org/2001/XMLSchema#string

Shantu G Amin

http://www.w3.org/2001/XMLSchema#string

William H Bisson

http://www.w3.org/2001/XMLSchema#string

Ying Lv

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term drug treatment for obesity: a systematic and clinical review

Bile acids: regulation of synthesis

FXR signaling in the enterohepatic system

FXR is a molecular target for the effects of vertical sleeve gastrectomy

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine

Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis

The RXR heterodimers and orphan receptors

MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity

Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes

Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human

P2888

P304

10166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS10166

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Patterson

Frank J. Gonzalez

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287120256

http://www.w3.org/2001/XMLSchema#string

P698

26670557

http://www.w3.org/2001/XMLSchema#string

P921

P932

4682112

http://www.w3.org/2001/XMLSchema#string